openPR Logo
Press release

Cardiac Markers Market Share 2022 Growth Challenges, Opportunities and Future Trends 2028

03-24-2022 08:01 AM CET | Health & Medicine

Press release from: Orion Market Research

The global cardiac markers market is expected to grow at a significant CAGR during the forecast period (2022-2028). When the heart is strained or its muscles are injured, cardiac markers or cardiac biomarkers are released into the bloodstream. These markers include cardiac troponins, creatine kinase (CK), ischemia-modified albumin (IMA), and myoglobin, among other enzymes, hormones, and proteins. These markers can be measured and tested to aid in the diagnosis of heart diseases such as myocardial ischemia and acute coronary syndrome (ACS). Electrocardiograms (ECGs) and clinical history are currently employed in diagnostic systems to determine the risk of certain disorders. These methods are insufficient and can lead to misdiagnosis or treatment delays. Cardiac marker testing is gaining popularity since it is more accurate and can detect problems in the early stages of presentation.

To Request a Sample of our Report on Cardiac Markers Market: https://www.omrglobal.com/request-sample/cardiac-markers-market

Lifestyle diseases including hypertension, obesity, dyslipidemia, and diabetes, all of which are substantial risk factors for CVD, are also on the rise, which in turn is contributing to the growth of the global cardiac marker market. It is estimated that 93 million adults in the US are obese or clinically obese, with a BMI of 30 or more. Obesity affects about 650 million people globally. As per World Health Organization (WHO), CVDs claimed the lives of 17.9 million people globally in 2019, accounting for 32% of all mortalities. Heart attacks and strokes were responsible for 85% of these deaths. Low- and middle-income nations account for about three-quarters of CVD mortality. CVDs were responsible for 38% of the 17 million premature mortalities (before the age of 70) caused by noncommunicable diseases in 2019. Furthermore, various private and public organisations are engaging in R&D operations in the field of cardiac biomarkers to create innovative technology. For instance, blood tests for high-sensitivity cardiac troponin have been shown to identify patients at higher risk of a second heart attack.

Market Coverage

· The market number available for - 2021-2028

· Base year- 2021

· Forecast period- 2022-2028

Segment Covered-

· By Product

· By Application

· By Testing Type

Regions covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape: F. Hoffmann-La Roche Ltd., Abbott Laboratories, and bioMérieux SA, among others.

(Get 15% Discount on Buying this Report)

A full Report of Cardiac Markers Market is Available @ https://www.omrglobal.com/industry-reports/cardiac-markers-market

Global Cardiac Markers Market Report by Segment

By Product

· Troponins (T and I)

· Myocardial Muscle Creatine Kinase (CK-MB)

· Myoglobin

· Brain Natriuretic Peptide (BNPs) or NT-proBNP

· Ischemia Modified Albumin (IMA)

· Others

By Application

· Myocardial Infarction

· Congestive Heart Failure

· Acute Coronary Syndrome

· Others

By End-User

· Laboratory Testing

· Point-of-Care Testing

Global Cardiac Markers Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiac Markers Market Share 2022 Growth Challenges, Opportunities and Future Trends 2028 here

News-ID: 2585513 • Views:

More Releases from Orion Market Research

Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry Growths to 2033
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034. SNP genotyping Market Overview The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This
Portable Ultrasound Device Market : A Guide to Understanding the Process
Portable Ultrasound Device Market : A Guide to Understanding the Process
Portable ultrasound device market was valued at approximately USD 2.16 billion, and it is projected to reach around USD 3.94 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 6.20% from 2024 to 2033. Portable Ultrasound Device Market Overview The portable ultrasound device market is experiencing significant growth, driven by advancements in imaging technology, the increasing demand for point-of-care diagnostics, and the rising prevalence of chronic diseases. These compact

All 5 Releases


More Releases for Cardiac

Cardiac Resynchronization Therapy: Driving Innovation and Transforming Global Ca …
London, UK - August 2025 | Strategic Revenue Insights Inc. The global cardiac resynchronization therapy (CRT) market is emerging as one of the most crucial sectors in cardiovascular healthcare, offering life-saving solutions for patients with heart failure and conduction abnormalities. CRT devices, including pacemakers and defibrillators, are designed to restore synchronized heart contractions, significantly improving patient survival rates and quality of life. With rising cardiovascular disease prevalence worldwide, CRT has
Mobile Cardiac Telemetry Systems Market Redefining Remote Cardiac Monitoring
"In recent years, the global Mobile Cardiac Telemetry Systems Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Mobile Cardiac Telemetry Systems Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot
Ambulatory Cardiac Monitoring Devices Market: Revolutionizing Cardiac Care
In the rapidly evolving landscape of healthcare, the Ambulatory Cardiac Monitoring Devices Market stands out as a beacon of innovation and progress. These devices, including ECG devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry, have become indispensable tools for healthcare professionals in managing and diagnosing cardiac conditions. As heart-related issues continue to afflict millions globally, the demand for advanced cardiac monitoring solutions is on the rise. Request
Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Precision Monito …
Newark, New Castle, USA: The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cardiac Monitoring & Cardiac Rhythm Management Devices
Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest. Browse 145 Market Data Tables and 119 Figures spread
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,